Nov 8, 2018 | BIOPORT ATLANTIC, Coloursmith Labs Inc., News, THE BIOINNOVATION CHALLENGE
Halifax, NS – November 8, 2018 – Today Picomole from Moncton, New Brunswick was named the winner of BioNova’s eighth annual BioInnovation Challenge (BIC) business pitch competition at BioPort 2018. Picomole is an innovative medical technology company with the goal of developing their patented and patent-pending technologies for breath analytics into the standard of care for non-invasive clinical diagnostics and personalized medicine.
Stephen Graham of Picomole said, “This experience has been invaluable. The mentorship and training we’ve received through this process has helped take Picomole to the next level, and we know the funding and the advisory services will help to elevate us even more.”
Atlantic Canada’s best health and life science innovators participate in the BioInnovation Challenge (BIC) business pitch competition each year. The competition’s goal is to help ease the transition from research laboratory to market. Picomole will receive a prize package that includes $25,000 in seed funding and an advisory services package worth more than $30,000. Picomole was up against Matthew Kay, CEO ofTalem Health Analytics and Gabrielle Masone, CEO of Coloursmith Labs.
“Our panel of judges had a difficult time selecting a winner because all seven finalists have what it takes to make their start up a success,” said Scott Moffitt, Executive Director of BioNova. “Congratulations to Picomole.”
The Judging Panel:
Jennifer Hamilton, Senior Director, New Ventures (Canada), Johnson & Johnson Innovation
Gerry Lacroix, Technology Sector Leader – Nova Scotia, Grant Thornton LLP
John Holyoake, Managing Director, Investment Banking, Bloom Burton & Co.
-30-
Contact:
Shana Cristoferi, Marketing Manager, BioNova
Mobile: (902) 830-9193
[email protected]
About BioNova
BioNova leads, accelerates, and advocates for Nova Scotia’s growing health and life sciences sector. Since 1993, BioNova has been accelerating the growth of its member companies. By hosting networking and educational events, and providing connections to potential funders and business resources, BioNova helps companies succeed. While these companies commercialize life-changing research to improve healthcare, provide healthier food, and develop sustainable solutions, BioNova advocates on behalf of the sector. BioNova champions the sector’s cluster of world-class research facilities, incubator programs, and companies who, together, bring investment and jobs to Nova Scotia. www.bionova.ca
About BioPort 2018
The 17th annual BioPort conference will take place at the Halifax Convention Centre on November 7-8, 2018. BioPort provides a forum to educate, inform and inspire the health and life sciences community to develop their ideas, commercialize their technologies and build links within the region and with guests brought in from the U.S. and from around the world. www.bioportatlantic.ca]]>
Nov 6, 2018 | Electric Puppets
Read the original article here
Despite the rapid uptake of digital technology in many of today’s biggest industries — with gaming and entertainment leading the way — the healthcare sector is slow to adapt to change.
Halifax-based Electric Puppets, headed by CEO Ryan Cameron, aims to help them on their way.
The company, under Cameron’s direction, offers solutions to real-world problems by harnessing…
Continue reading]]>
Nov 5, 2018 | News, Precision BioLogic
About Affinity Biologicals
Affinity Biologicals Inc. was founded in 1987 by Hugh and Patricia Hoogendoorn. With a strong background in hemostasis research and a focus on reagent and assay development, Affinity has become a primary manufacturer of more than 300 reagents and kits used in hemostasis and thrombosis research and diagnostics. Affinity’s product line includes: an extensive line of coagulation related antibodies, conjugates, matched-pair antibody sets for immunoassay of human and animal analytes, the VisuLize™ line of complete ELISA kits, and a full line of human plasma products including VisuDep™ Immune-Depleted Factor-Deficient Plasmas, VisuCal™ Calibrator Plasma and VisuCon™ Control Plasmas. Services include protein purification, antibody production, assay development, custom manufacturing including custom lyophilization and proficiency testing materials. All products are manufactured in its Ancaster, ON (Canada) facility, products are sold direct in North America and worldwide through a network of branded and private-label distributors. For more information, visit www.affinitybiologicals.com.
About Precision BioLogic
Precision BioLogic Inc. is a privately-held company that develops, manufactures and markets the cryocheck™ line of frozen products used by medical professionals and researchers around the globe to diagnose coagulation disorders. Precision BioLogic also has several active initiatives with pharmaceutical partners who seek to ensure that the diagnostic implications for their novel therapeutic agents have been well characterized. For more information, visit www.precisionbiologic.com.
For more information, contact:
Elaine Benoit, Marketing & Communications Manager, Precision BioLogic
[email protected] / 902.430.7795]]>
Nov 1, 2018 | News
BioPort 2018 Conference to Address Impact of Technology on Health and the Emerging Medical Cannabis Market
NEWS RELEASE: November 1, 2018 – Halifax, NOVA SCOTIA – BioPort 2018, Atlantic Canada’s largest health and life sciences industry conference, is set to explore trends transforming the industry. This year’s conference will focus on The Future of Health, with sessions covering the impact of new technology on health and the value of the emerging medical cannabis market. The Conference, hosted by BioNova, attracts health and life sciences innovators, industry leaders, and investors from across North America and will take place November 7-8, 2018 at the Halifax Convention Centre, in Halifax, Nova Scotia.
“BioPort provides a venue to highlight the accelerating momentum of the global health and life sciences sector, providing expert perspectives on opportunities and showcasing some of Atlantic Canada’s most ground-breaking, bio-focused entrepreneurs,” says Andy Fillmore, Parliamentary Secretary to the Minister of Canadian Heritage and Multiculturalism and Member of Parliament for Halifax, on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for the Atlantic Canada Opportunities Agency (ACOA). “From foundational research to new disruptive innovations coming to market, BioPort creates the right conditions to build on Atlantic Canada’s unique strengths in biotechnology as we continue to discover how new intelligence impacts health and life sciences in Atlantic Canada.”
This year’s conference will feature two keynote speakers. Dr. Corinna Lathan, ranked as one of the ‘Top 100 World Innovators’ by MIT Technology Review, will be delivering the evening keynote on the impact of technology on health at 6:00 pm on Wednesday, November 7, 2018. Jeremie Saunders, host of highly-acclaimed Sickboy podcast will deliver the afternoon keynote on the need for continued health innovation at 12:30 pm on Thursday, November 8, 2018.
“As Atlantic Canada’s health and life sciences sector continues to expand, we seek to evolve the topics we choose to feature at BioPort,” said Scott Moffitt, Executive Director of BioNova. “Our sessions explore how embracing disruptive technologies, like artificial intelligence, and uncovering emerging markets, like the value of natural products, present opportunities to grow our sector.”
BioPort 2018 also showcases Atlantic Canada’s best health and life science innovators in its BioInnovation Challenge (BIC) business pitch competition. New to this year’s program is BIC Junior, a pitch competition for students that aims to cultivate the next generation of health and life sciences innovators.
Atlantic Canada’s commercial health and life sciences sector is tapping into the $9 trillion global marketplace. Over 600 products are shipped to more than 80 countries. Nova Scotia presently has 185 products in development with $78 million committed to research and development. The sector has also generated over $1 billion in financial exits over the past six years.
Details of the conference program and schedule can be found at www.bioportatlantic.ca.
All media are asked to register by contacting [email protected].
-30-
Contact:
Shana Cristoferi, Marketing Manager, BioNova
Mobile: (902) 830-9193
[email protected]
About BioNova
BioNova leads, accelerates, and advocates for Nova Scotia’s growing health and life sciences sector. Since 1993, BioNova has been accelerating the growth of its member companies. By hosting networking and educational events, and providing connections to potential funders and business resources, BioNova helps companies succeed. While these companies commercialize life-changing research to improve healthcare, provide healthier food, and develop sustainable solutions, BioNova advocates on behalf of the sector. BioNova champions the sector’s cluster of world-class research facilities, incubator programs, and companies who, together, bring investment and jobs to Nova Scotia. www.bionova.ca
About BioPort 2018
The 17th annual BioPort conference will take place at the Halifax Convention Centre on November 7-8, 2018. BioPort provides a forum to educate, inform and inspire the health and life sciences community to develop their ideas, commercialize their technologies and build links within the region and with guests brought in from the U.S. and from around the world. www.bioportatlantic.ca]]>
Nov 1, 2018 | Electric Puppets
Ryan Cameron
CEO, Electric Puppets
Ryan Cameron has been a serial innovator since 1997. In 2000, Ryan led a team to create the first interactive versions of the beloved Little Golden Books for Disney Interactive, and then became CTO of an international US based firm that delivered online education to fortune 100 corporate employees. Ryan was CTO of online educational companies for the next 10 years before starting his own innovative online educational company, and advised on international boards and organizations as well. Ryan created online educational products that won numerous awards and helped hundreds of thousands of fortune 500 employees learn important new skills in multi-year award winning online programs. Ryan joined Copernicus Studios in 2013 and led the interactive division to create one of the first speech recognition engines tuned to children’s voices to empower early literacy applications, and then founded Electric Puppets in 2016. Ryan is an avid rare book and antique collector and lives on an acreage in Chester, Nova Scotia.
Read the BioPort 2018 press release here ]]>
